# Temocillin in ESBL-Enterobacteriaceae Infections

> **NCT05413772** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 29 (actual)

## Conditions studied

- Infectious Disease

## Interventions

- **OTHER:** Temocillin

## Key facts

- **NCT ID:** NCT05413772
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-20
- **Primary completion:** 2022-11-24
- **Final completion:** 2022-11-24
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2023-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05413772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05413772, "Temocillin in ESBL-Enterobacteriaceae Infections". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05413772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*